These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 15350362

  • 1. Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer.
    Kalli KR, Bradley SV, Fuchshuber S, Conover CA.
    Gynecol Oncol; 2004 Sep; 94(3):705-12. PubMed ID: 15350362
    [Abstract] [Full Text] [Related]

  • 2. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells.
    Sartor CI, Dziubinski ML, Yu CL, Jove R, Ethier SP.
    Cancer Res; 1997 Mar 01; 57(5):978-87. PubMed ID: 9041204
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines.
    Koga M, Musgrove EA, Sutherland RL.
    Cancer Res; 1990 Aug 15; 50(16):4849-55. PubMed ID: 2379149
    [Abstract] [Full Text] [Related]

  • 4. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
    Tuck AB, Hota C, Wilson SM, Chambers AF.
    Oncogene; 2003 Feb 27; 22(8):1198-205. PubMed ID: 12606946
    [Abstract] [Full Text] [Related]

  • 5. Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma.
    Liu Y, Poon RT, Shao W, Sun X, Chen H, Kok TW, Fan ST.
    Cancer Lett; 2007 Apr 08; 248(1):32-40. PubMed ID: 16837130
    [Abstract] [Full Text] [Related]

  • 6. Suppression of ovarian cancer cell tumorigenicity and evasion of Cisplatin resistance using a truncated epidermal growth factor receptor in a rat model.
    Chan JK, Pham H, You XJ, Cloven NG, Burger RA, Rose GS, Van Nostrand K, Korc M, Disaia PJ, Fan H.
    Cancer Res; 2005 Apr 15; 65(8):3243-8. PubMed ID: 15833856
    [Abstract] [Full Text] [Related]

  • 7. 2C4, a monoclonal antibody against HER2, disrupts the HER kinase signaling pathway and inhibits ovarian carcinoma cell growth.
    Takai N, Jain A, Kawamata N, Popoviciu LM, Said JW, Whittaker S, Miyakawa I, Agus DB, Koeffler HP.
    Cancer; 2005 Dec 15; 104(12):2701-8. PubMed ID: 16265675
    [Abstract] [Full Text] [Related]

  • 8. Evidence for the involvement of transforming growth factor alpha and epidermal growth factor receptor autocrine growth mechanism in primary human ovarian cancers in vitro.
    Morishige K, Kurachi H, Amemiya K, Fujita Y, Yamamoto T, Miyake A, Tanizawa O.
    Cancer Res; 1991 Oct 01; 51(19):5322-8. PubMed ID: 1717146
    [Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor receptor in cultured human retinal pigment epithelial cells.
    Yan F, Hui YN, Li YJ, Guo CM, Meng H.
    Ophthalmologica; 2007 Oct 01; 221(4):244-50. PubMed ID: 17579290
    [Abstract] [Full Text] [Related]

  • 10. Differential responses of EGFR-/AGT-expressing cells to the "combi-triazene" SMA41.
    Matheson SL, McNamee JP, Jean-Claude BJ.
    Cancer Chemother Pharmacol; 2003 Jan 01; 51(1):11-20. PubMed ID: 12497201
    [Abstract] [Full Text] [Related]

  • 11. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.
    Migliaccio A, Di Domenico M, Castoria G, Nanayakkara M, Lombardi M, de Falco A, Bilancio A, Varricchio L, Ciociola A, Auricchio F.
    Cancer Res; 2005 Nov 15; 65(22):10585-93. PubMed ID: 16288052
    [Abstract] [Full Text] [Related]

  • 12. E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancer.
    Reimer D, Hubalek M, Riedle S, Skvortsov S, Erdel M, Concin N, Fiegl H, Müller-Holzner E, Marth C, Illmensee K, Altevogt P, Zeimet AG.
    Cancer Res; 2010 Jun 01; 70(11):4613-23. PubMed ID: 20460525
    [Abstract] [Full Text] [Related]

  • 13. Selective downregulation of EGF receptor and downstream MAPK pathway in human cancer cell lines by active components partially purified from the seeds of Livistona chinensis R. Brown.
    Huang WC, Hsu RM, Chi LM, Leu YL, Chang YS, Yu JS.
    Cancer Lett; 2007 Apr 08; 248(1):137-46. PubMed ID: 16919867
    [Abstract] [Full Text] [Related]

  • 14. EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor.
    Henic E, Sixt M, Hansson S, Høyer-Hansen G, Casslén B.
    Gynecol Oncol; 2006 Apr 08; 101(1):28-39. PubMed ID: 16263158
    [Abstract] [Full Text] [Related]

  • 15. Human papillomavirus 16 immortalization of normal human ectocervical epithelial cells alters retinoic acid regulation of cell growth and epidermal growth factor receptor expression.
    Sizemore N, Rorke EA.
    Cancer Res; 1993 Oct 01; 53(19):4511-7. PubMed ID: 8402622
    [Abstract] [Full Text] [Related]

  • 16. Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.
    Stabile LP, Lyker JS, Gubish CT, Zhang W, Grandis JR, Siegfried JM.
    Cancer Res; 2005 Feb 15; 65(4):1459-70. PubMed ID: 15735034
    [Abstract] [Full Text] [Related]

  • 17. Three novel hormone-responsive cell lines derived from primary human breast carcinomas: functional characterization.
    Vázquez SM, Mladovan A, Garbovesky C, Baldi A, Lüthy IA.
    J Cell Physiol; 2004 Jun 15; 199(3):460-9. PubMed ID: 15095293
    [Abstract] [Full Text] [Related]

  • 18. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
    Johnson FM, Saigal B, Donato NJ.
    J Cell Physiol; 2005 Nov 15; 205(2):218-27. PubMed ID: 15887238
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of chemomigration of a human prostatic carcinoma cell (TSU-pr1) line by inhibition of epidermal growth factor receptor function.
    Zolfaghari A, Djakiew D.
    Prostate; 1996 Apr 15; 28(4):232-8. PubMed ID: 8602399
    [Abstract] [Full Text] [Related]

  • 20. Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells.
    Syed V, Ulinski G, Mok SC, Yiu GK, Ho SM.
    Cancer Res; 2001 Sep 15; 61(18):6768-76. PubMed ID: 11559549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.